| Name | Lacutamab |
|---|
| Description | Lacutamab (IPH4102) is a humanized monoclonal antibody (mAb) directed against the immune receptor molecule KIR3DL2, produced by recombinant technology in CHO cells. Lacutamab can be used in research of cutaneous T-cell lymphoma[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |